A Study Investigating the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Olamkicept in Healthy Persons
Condition(s):Inflammatory Gastrointestinal DiseasesLast Updated:March 7, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Inflammatory Gastrointestinal DiseasesLast Updated:March 7, 2024Recruiting
Condition(s):Ulcerative ColitisLast Updated:February 15, 2024Not yet recruiting
Condition(s):Infertility, FemaleLast Updated:December 28, 2023Not yet recruiting
Condition(s):Bladder CancerLast Updated:March 8, 2024Recruiting
Condition(s):Postpartum HemorrhageLast Updated:September 26, 2023Completed
Condition(s):Recurrence of Clostridium Difficile InfectionLast Updated:December 19, 2023Recruiting
Condition(s):Clostridium Difficile Infection RecurrenceLast Updated:March 7, 2024Recruiting
Condition(s):Bladder CancerLast Updated:February 23, 2024Recruiting
Condition(s):InfertilityLast Updated:January 9, 2023Withdrawn
Condition(s):Controlled Ovarian StimulationLast Updated:September 29, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.